Xinhua's "Xinhua Viewpoint" featured the National Center for Technology Transfer in Biomedicine (Jiangsu, Nanjing) in the Jiangbei New Area, where Eynos appears as a university spin-off case.
This page summarises a media report about Eynos. Quoted wording — including terms such as "breakthrough", "on par with", "first" or "unique" — is the original reporter's language and is not a performance claim by the company. Product performance is defined by the manual and the measured data. All products are for research use only (RUO) and are not intended for diagnostic or therapeutic use.
The programme, broadcast on 22 April 2026, looked at how Jiangsu translates university research into companies. Eynos was presented as one of the projects that moved from a laboratory result to a registered company inside the centre.
The report focuses on the transfer model rather than on individual products: laboratory space, shared instrumentation and a staged review process, with the founding team staying responsible for the technical decisions.
The full report is published in Chinese: 中文原文. This page is an English summary prepared by Eynos.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.